Profile
Dr. Christian C.
Fritz is Vice President-Biology at Syros Pharmaceuticals, Inc.
Dr. Fritz was previously employed as a Principal by Max-Planck Institute of Psychiatry, Senior Director-Cancer Cell Biology by Infinity Pharmaceuticals, Inc., and Senior Scientist by Millennium Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Hannover and a doctorate degree from Universität zu Köln.
Former positions of Christian C. Fritz
| Companies | Position | End |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-11-30 |
| Max-Planck Institute of Psychiatry | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| INFINITY PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Christian C. Fritz
| University of Hannover | Undergraduate Degree |
| Universität zu Köln | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SYROS PHARMACEUTICALS, INC. | Health Technology |
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Max-Planck Institute of Psychiatry |
- Stock Market
- Insiders
- Christian C. Fritz
